Article info

Download PDFPDF

1ISG-022 Economic analysis after the incorporation of bevacizumab biosimilar in a third level hospital
Free

Authors

Citation

Infante A, Castaño B, Èspinosa M, et al
1ISG-022 Economic analysis after the incorporation of bevacizumab biosimilar in a third level hospital

Publication history

  • First published March 14, 2021.
Online issue publication 
March 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.